James Helliwell
Förmögenhet: 7 M $ per 2026-07-31
Förmögenhet: 7 M $ per 2026-07-31
James A. Helliwell is the founder of Eupraxia Pharmaceuticals, Inc., founded in 2011, where Dr. Helliwell holds the titles of Chief Executive Officer & Director.
Dr. Helliwell is also the founder of Accuro Technologies, Inc...
Dr. Helliwell is currently the Chairman at Guidestar Medical Devices.
Formerly, Dr. Helliwell was an Assistant Professor at the University of British Columbia.
Dr. Helliwell completed undergraduate education at the University of British Columbia.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-06-15 | 1 055 012 ( 1,61 % ) | 7 M $ | 2026-07-31 |
| Företag | Position | Start |
|---|---|---|
| EUPRAXIA PHARMACEUTICALS INC. | Grundare | 2011-05-12 |
Guidestar Medical Devices
Guidestar Medical Devices Medical SpecialtiesHealth Technology Designs and manufactures medical devices | Ordförande | - |
Accuro Technologies, Inc. | Verkställande Direktör | - |
| Företag | Position | Slut |
|---|---|---|
University of British Columbia
University of British Columbia Other Consumer ServicesConsumer Services Functions as a College/University | Företagsledare/Principal | - |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 4 |
|---|---|
Eupraxia Pharmaceuticals, Inc.
Eupraxia Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company focused on the development of delivered, extended-release alternatives to currently approved drugs | Health Technology |
University of British Columbia
University of British Columbia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Accuro Technologies, Inc. | |
Guidestar Medical Devices
Guidestar Medical Devices Medical SpecialtiesHealth Technology Designs and manufactures medical devices | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån